Heart Failure: Perspectives

• Jan 05 2024 This Week in Cardiology   Neuro-modulation in HF, private equity owned hospitals, HCM, SCD and ICD re-evaluated, and peer review are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, January 05, 2024
  4
• Topics Cardiologists Love to Hate: MOC and AI   Bob Harrington and Mike Gibson discuss two of the hottest topics in cardiology and medicine for 2023: a proposed alternative to the maintenance of certification process, and artificial intelligence.
  theheart.org on Medscape, December 29, 2023
  7
• The Ethics of Sham PCI and Clinical Relevance of ORBITA-2   John Mandrola asks Rasha Al-Lamee and Christopher Rajkumar to address criticisms of the ethics and clinical relevance of their pivotal ORBITA-2 trial.
  theheart.org on Medscape, December 27, 2023
• CPAP Oversells and Underperforms The pressure pushers have been undeterred by evidence, says Dr Holley.
  Medscape Critical Care, December 22, 2023
  92
• Mandrola's Top 10 Cardiology Stories of 2023 Obesity drugs, factor XI inhibitors, and procedures such as TAVR, PCI, and TEER are among the top stories of 2023, according to cardiologist John Mandrola, MD.
  theheart.org on Medscape, December 20, 2023
  3
• The Top Cardiology Trials of 2023   For this year's review, Bob Harrington and Mike Gibson revisit the major cardiology conferences -- from ACC in New Orleans to AHA in Philly.
  theheart.org on Medscape, December 15, 2023
• The Truth About Vaping   The idea that vaping is harmless is going up in smoke. What would you tell your own kids or grandkids about e-cigarette use?
  Medscape Family Medicine, December 11, 2023
  46
• Dec 08 2023 This Week in Cardiology   Three aspects of the recent AF guideline documents and a possible new treatment of POTS are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, December 08, 2023
  5
• Key Updates in Obesity From AHA 2023   Highlights in obesity from AHA 2023 include an overview of the SELECT and SURMOUNT trials, cost-effectiveness of weight loss therapies, and the association of obesity with the risk for heart failure.
  Medscape, December 06, 2023
• Clinical Practice Guidelines on SGLT-2 Inhibition in Adult Kidney Disease (UKKA, 2023) Updated 2023 clinical practice guidelines on SGLT-2 inhibition in adult kidney disease published by the UK Kidney Association in BMC Nephrology.
  Medscape, December 06, 2023
  1
• Return to Play in Athletes With Acute Myocarditis An expert analysis of the recommended protocol.
  ACC.org, December 06, 2023
  2
• Parenting the Addicted: Scenes From a Substance Abuse Clinic Parenting an adult child with a substance abuse problem often involves making painful choices that look senseless — or worse — to an outsider.
  Medscape Internal Medicine, December 04, 2023
  5
• Predicting HF Worsening: Speech Analysis Beats Weighing Scales   Heart failure experts, Ileana Piña and Bill Abraham, discuss the HearO study on the use of AI for detecting congestion remotely and other tips and tricks they have learned over the years.
  theheart.org on Medscape, December 04, 2023
• Dec 01 2023 This Week in Cardiology   More from AHA including SGLT2 inhibitors, blood transfusion after MI; cracks in the armor of Factor XI inhibitors; and renal denervation are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 01, 2023
  2
• Key Updates in Diabetes From AHA 2023   Highlights in diabetes from AHA 2023 include a meta-analysis of the DAPA-HF and DELIVER trials, therapeutic effects of SGLT2 inhibitors, and the lag in uptake of this therapy in the clinical setting.
  Medscape, December 01, 2023
• Diabetes and Metabolism Updates From ASN 2023   Highlights in diabetes and metabolism from ASN 2023 include the AYAME trial, examining bardoxolone methyl in diabetic kidney disease, as well as a novel aldosterone synthase inhibitor and zibotentan.
  Medscape, November 27, 2023
• Alcohol Abuse: Don’t Drink to That People who chronically abuse alcohol are at increased risk for cirrhosis, GI bleeding, pancreatitis, cardiomyopathy, trauma, mental health disorders, and a wide variety of cancers. Learn more about the potentially devastating complications of excessive, long-term alcohol use.
  November 21, 2023
• Diagnosing Cardiac Amyloidosis: 5 Things to Know Dr Taylor Lebeis highlights the key aspects of a diagnostic workup for cardiac amyloidosis.
  American College of Cardiology & Medscape , November 20, 2023
• When to Order Antinuclear Antibodies in Primary Care   Tips from an expert rheumatologist also reveal when not to order ANA and how to interpret the results.
  The Curbsiders, November 14, 2023
  2
• Maternal Perinatal Mortality: A Pediatric Issue Dr Barbara Howard "recently become aware of new data that changes my ideas about what we pediatricians need to be doing as part of our care for children and their families."
  MDedge, November 13, 2023